digital

Pharma Hotlist: Apps are Good Medicine

In an ongoing series, Q&A sessions with media experts from CMI/Compas explore what pharma needs to know about how physicians…

White Paper

Share

Digital Ad Verification: A CMI/Compas Whitepaper

Fraudulent advertising behaviors are becoming more prevalent, costing advertisers millions of dollars a month in wasted ad impressions and clicks. In this CMI/Compas whitepaper, our experts explain what you need to know about digital ad verification and what CMI/Compas is doing to address the challenges of viewability, placement verification, and fraudulent activity.

The Domain Conundrum

As brand planning for a launch brand moves forward, one of the most highly debated topics is often related to…

Rich Media Banners: What, Why & How

What is a Rich Media Banner? A rich media banner is interactive digital banner advertising that drives response with its…

The Advantages of E-Detailing- For Pharma Marketers

Subject: Pharma marketers have to find innovative and cost-effective ways to engage busy physicians yet still deliver positive ROI. E-details…

Viewable Impressions

Background: A viewable impression is a technology able to calculate the rate a display ad has actually been visible on…

Google Analytics Event Tracking

Background and Insutry Analysis:  Google Analytics (GA) rolled out event tracking in 2007, but many website owners still aren’t taking…

Google’s Knowledge Panel

Background: On November 30, Google began piloting Knowledge Panel, an add-on to Knowledge Graph, which launched in May. Knowledge Graph…

Impact of iPad on Medical Reprints Market

Background: More pharmaceutical companies are moving away from traditional paper reprints and are arming their sales force with digital ePrints…